P&G Q4 update
This article was originally published in The Rose Sheet
Executive SummarySales projected to grow 6%-7% in the fourth quarter (ending June 30) with foreign exchange expected to contribute 3%-4% to the top line and acquisitions and divestitures to have a negative 1% impact, Procter & Gamble reports June 5. Sales expectations have been adjusted to reflect impact of a tornado that struck firm's Jackson, Tenn. Pringles manufacturing facility in May. Core earnings per share, excluding restructuring charges, are expected to grow 12%. Separately, P&G says it is launching additional tender offer period for Wella shareholders June 6 and will not change offer price for voting shares and preference shares during that period. P&G acquired approximately 5 mil. voting shares and 1.5 mil. preference shares, representing total of 9.69% of registered share capital during initial tender period...
You may also be interested in...
Yes To is investigating reports – including posts on leading social media platforms – regarding irritation and redness experienced by children and other users of its Yes To Grapefruit Glow-Boosting Unicorn Paper Mask. In the meantime, the company is recalling the product voluntarily.
A maker of low-level LED light-therapy devices was cited by the US FDA for premarket, quality systems and Medical Device Reporting violations. It's just one of two device-related warning letters released by the agency this week.
Compliance Corner: The 10 Best – And 10 Worst – Things You Can Do When FDA Inspects Your Firm (Part 6)
A panel of longtime industry experts offer manufacturers a list of things they should and shouldn’t do when an investigator from the US agency knocks on their facility door. In this sixth installment of a 10-part series, experts David Elder and John McKay address communication between the front room – where investigators do the majority of their work – and the back room, used by company workers to fulfill investigator requests for documents, records and other information.